Cervical Cancer · LIVING RESEARCH LIBRARY

Ongoing Research for Cervical Cancer Using Advanced Alternative Medicine

Explore positive published findings by substance, cancer biology, treatment interaction and quality-of-life outcome.

Every entry includes the original study title, year, concise finding and a direct PubMed link.

Call 1.800.923.7878

Ask About Your Cervical Cancer Case

Tell us the diagnosis, stage, biomarkers, current treatment plan and research questions you want to understand. Our Patient Care Team will follow up personally.

Prefer to speak now?
Call 1.800.923.7878

Explore this cancer section

Cervical Cancer

Living research library · positive published findings

Research organized by substance and finding

Browse 19 source-linked studies with the full title, publication year, research focus and a concise finding. Select any linked substance to move directly to its corresponding Sunridge page.

Mechanisms underlying the therapeutic effects of Amygdalin in treating Cervical Cancer based on multi-omics analysis.

2026 · Apoptosis and cell death

Cell experiments have shown that Amygdalin inhibits the proliferation of cervical cancer HeLa and SiHa cells in a dose- and time-dependent manner, and induces cell apoptosis.

Open study on PubMed →

Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis.

2023 · Apoptosis and cell death

Dihydroartemisinin (DHA), the primary active metabolites of artemisinin and its derivatives, has exhibited a variety of anticancer properties with low toxicity.

Open study on PubMed →

Berberine: A dual anti-HIV and anti- cervical cancer compound.

2024 · Cancer biology and response

We report the effects of berberine (BBR), a benzylisoquinoline alkaloid small molecule on inhibition of HIV infection of cervical cancer cells.

Open study on PubMed →

Curcumin Nanoformulation for Cervical Cancer Treatment.

2016 · Cancer biology and response

Curcumin (CUR) is a well-known natural compound, which exhibits excellent anti-cancer potential by regulating many proliferative, oncogenic, and chemo-resistance associated genes/proteins.

Open study on PubMed →

EGCG remodels the TGF-β cervical cancer micro-environment towards immune responsiveness.

2025 · Apoptosis and cell death

EGCG treatment under TGF-β, reduced PD-L1, CD55 and CD46 expression, decreased viability, metabolic activity and MMP-2 secretion, while inducing apoptosis in SiHa co-culture.

Open study on PubMed →

Ginseng Glucosyl Oleanolate Suppresses Cervical Cancer via Simultaneous Inhibition of Glycolysis and Oxidative Phosphorylation In Vivo/Vitro.

2025 · Metabolism and redox biology

Ginseng, a popular functional food, owes its benefits mainly to ginsenosides with reported antitumor activity that have been widely reported for its antitumor activity.

Open study on PubMed →

Identification of Glutathione Synthetase as a Therapeutic Target for Cervical Cancer via Combining Bioinformatics and Experimental Validation.

2025 · Tumor growth and proliferation

Drug sensitivity analysis linked GSS to vorinostat, which inhibits tumour growth by suppressing the PI3K/Akt pathway and downregulating GSS.

Open study on PubMed →

Retraction Note: Melatonin enhances TNF-α-mediated cervical cancer HeLa cells death via suppressing CaMKII/Parkin/mitophagy axis.

2023 · Cancer biology and response

The study reports retraction Note: Melatonin enhances TNF-α-mediated cervical cancer HeLa cells death via suppressing CaMKII/Parkin/mitophagy axis.

Open study on PubMed →

Characterization of cervical microbiota in cervical intraepithelial neoplasia and cervical cancer using low-coverage whole genome sequencing.

2025 · Cancer biology and response

CC microbiota showed significant Bacteroidetes enrichment (82% at class level) and reduced Firmicutes abundance.

Open study on PubMed →

Characterization of the vaginal microbiome of postmenopausal patients receiving chemoradiation for locally advanced cervical cancer.

2025 · Treatment response

We hypothesized that characteristics of the microbiome might correlate with treatment response.

Open study on PubMed →

The intratumoral microbiota heterogenicity is related to the prognosis and tumorigenesis of cervical cancer.

2025 · Immune and inflammatory signaling

The microbiome can influence cancer development by modulating inflammation, immune responses and metabolic pathways.

Open study on PubMed →

The Role of Intratumor Microbiomes in Cervical Cancer Metastasis.

2023 · Metastasis and invasion

The relationship between intratumor microbiomes and cervical cancer metastasis, however, remains unclear.

Open study on PubMed →

Zhidai Decoction Inhibits Cervical Cancer through Regulation of Vaginal Microbiota.

2020 · Cancer biology and response

In conclusion, ZDD displayed inhibitory effect on cervical cancer, and it might be based on restoring the balance of vaginal microbiota.

Open study on PubMed →

Investigating the potential mechanism of quercetin against cervical cancer.

2023 · Cancer biology and response

Cervical cancer is emerging as a potential target of increased susceptibility to coronavirus disease-2019 (COVID-19), leading to compromised survival rates.

Open study on PubMed →

Quercetin up-regulates the expression of tumor-suppressive microRNAs in human cervical cancer.

2023 · Cancer biology and response

The results from this study show that quercetin has the potential to prevent cervical cancer by regulating the expression of tumor-suppressive miRNAs.

Open study on PubMed →

Resveratrol and Cervical Cancer: A New Therapeutic Option.

2023 · Metastasis and invasion

Among the herb-based components, resveratrol has several beneficial effects given its anticancer activities (e.g., anti-angiogenesis, anti-proliferation, anti-metastatic and pro-apoptotic).

Open study on PubMed →

Sodium selenite inhibits cervical cancer growth via ROS mediated AMPK/FOXO3a /GADD45a axis.

2022 · Tumor growth and proliferation

HeLa cell xenografts in female nude mice showed tumor growth retardation, with no obvious liver and kidney toxicity, after being intraperitoneally injected with 3 mg/kg sodium selenite (SS) for 14 days.

Open study on PubMed →

Sodium selenite inhibits cervical cancer progression via ROS-mediated suppression of glucose metabolic reprogramming.

2024 · Tumor growth and proliferation

Sodium selenite (SS) treated HeLa and SiHa cells were assessed for proliferation using the CCK-8 assay and immunofluorescence.

Open study on PubMed →

Cholecalciferol induces apoptosis via autocrine metabolism in epidermoid cervical cancer cells.

2022 · Apoptosis and cell death

The authors conclude that autocrine activation of cholecalciferol to calcidiol may mediate VDR signalling of growth inhibition and apoptosis in SiHa cells.

Open study on PubMed →

Scottsdale Clinic

14200 N Northsight Blvd #160
Scottsdale, Arizona 85260

Office Hours

Monday–Friday: 9:00 AM–5:00 PM
Saturday: 9:00 AM–12:00 PM

Visit Sunridge in Scottsdale

FREE INTRODUCTORY CALL

Speak With Our Patient Care Team

Tell us what you are facing. There is no charge to speak with our Patient Care Team, understand how Sunridge works and determine whether a physician consultation may be an appropriate next step.

Call Now: 1-800-923-7878

This introductory call is not a medical consultation and does not establish a physician-patient relationship.

Have a Question or Share Feedback:
It's easy to get in touch with us